CareDx Reports on Financial Performance in Fourth Quarter and Full Year 2022

CareDx, Inc. (Nasdaq: CDNA), The Transplant Company™, is set to report its financial results for the fourth quarter and full year 2022 on Monday, February 27, 2023 after market close. Company management will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time, providing a detailed overview of the results and further insights into the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers.

About CareDx – The Transplant Company

CareDx is leading the way in precision medicine solutions for transplant patients and their loved ones. Based in Brisbane, California, the company offers testing services, products, and digital healthcare solutions to provide comprehensive care along the pre- and post-transplant journey. CareDx is the leading provider of genomics-based information for transplant patients and strives to deliver clinically differentiated, high-value healthcare solutions.

Leave a Comment